StonvexLoading…
StonvexStonvexStonvexCore line items from APLD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $144.19M | $136.62M | $55.39M | $8.55M |
Operating Income | $-16.84M | $-32.85M | $-42.91M | $-20.90M |
Net Income | $-231.06M | $-149.27M | $-44.65M | $-23.52M |
EPS (Diluted) | $-1.16 | $-1.31 | $-0.47 | $-0.41 |
Total Assets | $1.87B | $762.87M | $263.96M | $119.98M |
Total Liabilities | $1.24B | $638.04M | $194.28M | $40.74M |
Cash & Equivalents | $41.55M | $3.34M | $29.00M | $38.80M |
Free Cash Flow OCF − CapEx | $-797.00M | $-128.01M | $-72.54M | $-59.12M |
Shares Outstanding | 224.91M | 139.05M | 95.93M | 97.80M |